New shot after heart attack may cut future risks

NCT ID NCT07142265

First seen Jan 04, 2026 · Last updated Apr 30, 2026 · Updated 16 times

Summary

This study tests whether giving a cholesterol-lowering drug called inclisiran soon after a heart attack can reduce the chance of another heart problem within a year. About 300 adults in Russia who have had a heart attack and high cholesterol will receive the drug early. Researchers will track heart-related events, cholesterol levels, and safety over 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Novartis Investigative Site

    RECRUITING

    Cheboksary, 428000, Russia

  • Novartis Investigative Site

    RECRUITING

    Grozny, 364051, Russia

  • Novartis Investigative Site

    RECRUITING

    Kemerovo, 650002, Russia

  • Novartis Investigative Site

    RECRUITING

    Moscow, 105203, Russia

  • Novartis Investigative Site

    RECRUITING

    Moscow, 119607, Russia

  • Novartis Investigative Site

    RECRUITING

    Novosibirsk, 630051, Russia

  • Novartis Investigative Site

    RECRUITING

    Penza, 440026, Russia

  • Novartis Investigative Site

    RECRUITING

    Petrozavodsk, 185019, Russia

  • Novartis Investigative Site

    RECRUITING

    Rostov-on-Don, 344010, Russia

  • Novartis Investigative Site

    RECRUITING

    S Petersburg, 192242, Russia

  • Novartis Investigative Site

    RECRUITING

    Syktyvkar, 167981, Russia

  • Novartis Investigative Site

    RECRUITING

    Tomsk, 634009, Russia

  • Novartis Investigative Site

    RECRUITING

    Ulan-Ude, 670031, Russia

Conditions

Explore the condition pages connected to this study.